Vertex Pharmaceuticals Incorporated
Clinical trials sponsored by Vertex Pharmaceuticals Incorporated, explained in plain language.
-
New narcolepsy drug VX-433 enters first human safety trial
Symptom relief Not yet recruitingThis early-stage study tests a new medicine called VX-433 for people with narcolepsy type 1. The main goals are to check if the drug is safe and how the body processes it. About 118 adults will take part. The study also looks at how VX-433 affects other drugs like midazolam and b…
Phase: PHASE1 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated May 17, 2026 03:00 UTC
-
Healthy volunteers needed to test pain drug interactions
Knowledge-focused Not yet recruitingThis early-stage study looks at how a drug called efavirenz changes the levels of a new pain medicine, suzetrigine, in the body. It involves 18 healthy adults and aims to understand safety and drug processing, not to treat pain. Results will help guide future use of suzetrigine.
Phase: PHASE1 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC